Skip to content

Study to see the effect of Rasnapanhak Ghanvati for treatment of Rheumatoid Arthritis

A Clinical study to evaluate the efficacy of Rasnapanchak Ghanvati in the management of Aamvata (Rheumatoid Arthritis) - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074758
Enrollment
30
Registered
2024-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Dr Abhilasha Balasaheb Waychal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical sign and symptoms of Aamvata like Shoola (pain), Shotha (swelling), Stmbha (stifness) in joints, Angamarda (bodyache), Trishna (thirst), Aalasya (laziness), Agnimandya (anorexia), Gaurv (heaviness).(Any three)

Exclusion criteria

Exclusion criteria: 1.Chronicity for more than 5 years 2.Patients having severe crippling deformity 3.Patients who are steroid dependent for relief of symptoms 4.Patients with past traumatic history

Design outcomes

Primary

MeasureTime frame
Improvement in sign and symptoms of AamvataTimepoint: 30 days study with follow up on 15th and 30th day.(0,15,30)

Secondary

MeasureTime frame
To observe the adverse effect, if any.Timepoint: 30 days study with follow up on 15th and 30th day.(0,15,30)

Countries

India

Contacts

Public ContactDr Abhilasha Balasaheb Waychal

Dr. D. Y. Patil University, Sant Tukaram Nagar, Pimpri, Pune. Maharashtra

vjayu82@gmail.com8983478062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026